share_log
Breakings ·  Mar 22, 2023 16:30
Huahai Pharmaceutical: The pharmaceutical product levaminapram sustained-release capsules obtained approval numbers from the US FDA.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment